Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance EA Pietilä, J Gonzalez-Molina, L Moyano-Galceran, S Jamalzadeh, ... Nature communications 12 (1), 3904, 2021 | 90 | 2021 |
Mesothelin-specific CAR T cells target ovarian cancer E Schoutrop, I El-Serafi, T Poiret, Y Zhao, O Gultekin, R He, ... Cancer Research 81 (11), 3022-3035, 2021 | 51 | 2021 |
Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance J Gonzalez-Molina, L Moyano-Galceran, A Single, O Gultekin, S Alsalhi, ... Seminars in Cancer Biology 86, 224-236, 2022 | 31 | 2022 |
FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation O Gultekin, J Gonzalez-Molina, E Hardell, L Moyano-Galceran, N Mitsios, ... NPJ Precision Oncology 5 (1), 97, 2021 | 11 | 2021 |
The extracellular matrix–immune microenvironment crosstalk in cancer therapy: challenges and opportunities L Closset, O Gultekin, S Salehi, D Sarhan, K Lehti, J Gonzalez-Molina Matrix Biology, 2023 | 5 | 2023 |
CD11c-CD8 spatial cross presentation: A novel approach to link immune surveillance and patient survival in soft tissue sarcoma Y Su, P Tsagkozis, A Papakonstantinou, NP Tobin, O Gultekin, ... Cancers 13 (5), 1175, 2021 | 4 | 2021 |
MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness J Gonzalez‐Molina, P Hahn, RM Falcao, O Gultekin, G Kokaraki, ... Molecular Oncology 18 (4), 850, 2024 | 3 | 2024 |
CXCR2-mediated recruitment of adaptive NK cells with NKG2C/HLA-E dependent antigen-specific memory enhances tumor killing in ovarian cancer Y Sun, A Rodgers-Furones, O Gultekin, S Khare, SY Neo, W Shi, ... | | 2024 |
Targeting immune and desmoplastic tumor microenvironment to sensitize gynecological cancer cells to therapy O Gultekin Inst för mikrobiologi, tumör-och cellbiologi/Dept of Microbiology, Tumor and …, 2024 | | 2024 |
Enhanced NK cell proficiency in solid tumors through antigen-specific memory via NKG2C/A-HLA-E/ABC recruited to tumors by CXCR2 Y Sun, AR Furones, O Gultekin, S Khare, SY Neo, W Shi, LM Galceran, ... bioRxiv, 2024.03. 28.585607, 2024 | | 2024 |
1000 Adaptive NK cells with distinct features possess immune memory towards ovarian tumors Y Sun, A Rodgers-Furones, S Suzuki, O Gultekin, L Galceran, S Salehi, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
2022-RA-717-ESGO Establishment of peritoneal dECM scaffolds for 3D culture of ovarian cancer organoids CH Gjerde, A Langer, GR de Garibay Ponce, K Kleinmanns, HN Dongre, ... International Journal of Gynecological Cancer 32 (Suppl 2), A406-A406, 2022 | | 2022 |
YAP and collagen remodelling support cell proliferation and tumour aggressiveness in uterine leiomyosarcoma J Gonzalez-Molina, P Hahn, RM Falcão, O Gultekin, G Kokaraki, ... bioRxiv, 2022.06. 27.497746, 2022 | | 2022 |
Regulatory FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation O Gultekin, J Gonzalez-Molina, E Hardell, L Moyano-Galceran, N Mitsios, ... bioRxiv, 2021.03. 26.437169, 2021 | | 2021 |
The Immune Microenvironment in Low-Grade Endometrial Stromal Sarcomas: The Ratio of CD8+ T-Cells/FOXP3+ Tregs (T Regulatory Cells) is a Significant Prognostic Factor E Hardell, J Gonzalez-Molina, O Gultekin, K Lehti, J Carlson LABORATORY INVESTIGATION 100 (SUPPL 1), 1065-1066, 2020 | | 2020 |
Conflict of interest statement E Schoutrop, I El-Serafi, T Poiret, Y Zhao, O Gultekin, R He, ... | | |